The Minerva Foundation for BC Women announced Lia Merminga, Head of Accelerator Division, as a recipient of the Women In Science award. Lia is recognized for her integrity, excellence, and vision.
Treating ocular melanoma since '95, the PT Facility at
TRIUMF is one of just 42 facilities worldwide capable of supplying proton beams, the technical know-how, and coordination with
local institutions to provide the best possible treatment
for this rare disease.
TRIUMF's Paul Schaffer was selected as one of Business in Vancouver's Top Forty under 40 this morning, recognizing BC professionals who've already made their mark. Congratulations!
For the first time ever, Astatine-209 was successfully recovered from TRIUMF's ISAC facility for use in nuclear medicine, a breakthrough in theranostic isotope research.
Last week, TRIUMF welcomed a delegation of senior scientists from the Japanese KEK laboratory as part of the the fourth joint Symposium on Accelerator-based Science. A new five-year partnership agreement was signed.
Now available online, Five-Year Plan 2015–2020 represents a defining document for TRIUMF. Not
only does it recap the performance of the five years—2008–2012—it also
presents an implementation plan for the second half of the decadal
vision laid out in Five-Year Plan 2010–2015.
After many trials and tribulations, the HERACLES experiment led by Laval University's René Roy has collected data for measurements of the symmetry term of nuclear potential.
The 2013 Nobel Prize in Physics was awarded to François Englert and Peter W. Higgs "for
the theoretical discovery of a mechanism that contributes to our
understanding of the origin of mass of subatomic particles, and which
recently was confirmed through the discovery of the predicted
fundamental particle, by the ATLAS and CMS experiments at CERN's Large
Hadron Collider."